All articles by Manish Kumar
Bio-Rad plans to buy digital PCR developer Stilla Technologies
Stilla Technologies develops next-gen digital PCR instruments and assays for genetic tests, including oncology diagnostics, gene therapy, and infectious diseases
InspireMD and NAMSA to partner on CGUARDIANS II trial of the CGuard Prime 80 cm carotid stent system
CGUARDIANS II is a prospective, multi-center, single arm pivotal study that aims to enroll a minimum of 50 evaluable patients
WhiteSwell reports data supporting treatment with eLym system
Results from expanded cohort of ongoing DELTA-HF study show patients were decongested with stable renal function and with few rehospitalizations at 90 days following treatment
GRAIL and Quest Diagnostics expand access to Galleri MCED test
The integration streamlines Galleri cancer test orders for physicians and increases access at Quest’s 7,400 patient access points in the US
Thermo Fisher launches Invitrogen EVOS S1000 for spatial tissue imaging
The system empowers researchers to enter spatial tissue proteomics, overcoming traditional microscopy limits and lowering entry barriers for advanced data creation
Biome Analytics launches advanced ECMO, heart transplant, and LVAD module
This advanced analytics module delivers deep insights into patient outcomes, program efficiency, and resource utilization by integrating clinical, operational, and financial data
Certain nano surface technology assets developed by Nanovis have been acquired by Medtronic
Nanovis’ FDA-Cleared Nanotechnology is Used to Enhance Medtronic PEEK Interbody Fusion Devices for Use in Spine Surgery
Neuvotion’s NeuStim secures FDA clearance for stroke, injury recovery
NeuStim is a non-invasive wearable that electrically stimulate muscles to aid hand movement recovery after stroke or spinal cord injury
Cubresa partners with Siemens for BrainPET scanner compatibility
Both companies will develop and test BrainPET compatibility with MAGNETOM MRI scanners, starting with Terra and Terra.X 7T models, expanding to others later
Symphony Robotics licenses new robotics technology to fight brain tumours
Symphony Robotics is now advancing the patents-pending technology, which combines micro-robotic arms, real-time computer vision, and state-of-the-art artificial intelligence